Could the world see a return of Measles?

In a recent study performed by analysts working for the BBC, vaccination rates and trends were measured for three deadly diseases-Measles, Hib3, and DTP3.  In the article, each disease was mapped in accordance to the availability of vaccines in each country. In addition, trend graphs were created to depict the level at which denizens were given vaccination for each disease. While some of the results seemed normal, others were definitely frightening. The first of which is Measles. Measles used to be one of the deadliest diseases to possess a few decades ago. The disease "is a highly infectious viral disease whose symptoms include a high fever and rash. Complications of measles can include blindness, brain swelling and pneumonia."  A vaccine for the disease was created in the 1960's and as a result "the number of deaths from the disease plummeted from 2.6 million in 1980 to 156,000 last year."  While immunization continues for Measles, particularly in the Western and newly developed worlds, there is concern that global immunization rates have leveled off in recent years. It has been found that children are the ones who are recently not being vaccinated. According to the W.H.O., it is "estimated that 1.5 million deaths children under five die each year  are from diseases that could have been prevented by routine immunization, such as Measles." Most of this is happening in places like Southeast Asia and regions in Africa. While major health initiatives led by global organizations have led to higher rates of vaccination in places like Africa (especially with Hib3), places like Southeast Asia still lag far behind. If you take a look at the graphs on the webpage, you can see that Africa and Southeast asia consistently fall below the global average in terms of vaccination rates, whereas Europe remains far above the average bar. While there already is much being done, global vaccination could still be much more efficient and wide-spread. As noted, there ARE vaccines for each of these diseases that have been proven to eradicate them from populations. In most cases, these vaccines can be fairly cheap and can be implemented efficiently when working in conjunction with aid organizations. Personally I believe that there needs to be better health initiatives implemented within regions that falter with vaccinations. As seen with Hib3 in Africa, adopting such initiatives greatly increased the level of vaccination of Hib3 and in turn led to fewer deaths ever recorded in such regions afflicted with the disease. 

I highly encourage you to check out this study and look through the data/graphs. Maybe you could formulate an innovative solution!

http://www.bbc.co.uk/news/health-24519949